Article citationsMore>>

FDA Drug Safety Communication (2015) FDA Revises Labels of SGLT2 Inhibitors for Diabetes to Include Warnings about Too Much Acid in the Blood and Serious Urinary Tract Infections. Posted 12 April 2015.

has been cited by the following article:

Contact us
Follow SCIRP
Twitter Facebook Linkedin Weibo
Free SCIRP Newsletters
Copyright © 2006-2021 Scientific Research Publishing Inc. All Rights Reserved.
Top